«Protection for the gut barrier: New approach may prevent graft - versus - host disease: Activating signal paths could protect patients from dangerous immune reactions after stem cell transplantations.»
Biotech company Trevana's drug, oliceridine, acts as a μ - opioid receptor to activate a pain - relieving signaling pathway with less triggering of a separate path that leads to depressed breathing.